Swedencare AB (SWDCF)
2.30
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Swedencare Gross Profit Margin (Quarterly) : 7.63% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.63% |
| March 31, 2026 | 7.60% |
| December 31, 2025 | 3.84% |
| September 30, 2025 | 6.78% |
| June 30, 2025 | 3.54% |
| March 31, 2025 | 6.72% |
| December 31, 2024 | 8.35% |
| September 30, 2024 | 8.41% |
| June 30, 2024 | 9.42% |
| March 31, 2024 | 8.92% |
| December 31, 2023 | 8.77% |
| September 30, 2023 | 7.94% |
| June 30, 2023 | 5.31% |
| March 31, 2023 | 6.06% |
| December 31, 2022 | 6.80% |
| September 30, 2022 | 3.54% |
| June 30, 2022 | 7.05% |
| March 31, 2022 | 8.92% |
| December 31, 2021 | 6.35% |
| September 30, 2021 | 9.61% |
| June 30, 2021 | 13.64% |
| March 31, 2021 | 8.91% |
| December 31, 2020 | 12.73% |
| Date | Value |
|---|---|
| September 30, 2020 | 30.22% |
| June 30, 2020 | 20.30% |
| March 31, 2020 | 25.08% |
| December 31, 2019 | 21.45% |
| September 30, 2019 | 33.98% |
| June 30, 2019 | 27.47% |
| March 31, 2019 | 33.06% |
| December 31, 2018 | 26.28% |
| September 30, 2018 | 35.75% |
| June 30, 2018 | 26.42% |
| March 31, 2018 | 26.15% |
| December 31, 2017 | 27.22% |
| September 30, 2017 | 27.90% |
| June 30, 2017 | 17.32% |
| March 31, 2017 | 31.05% |
| December 31, 2016 | 3.78% |
| September 30, 2016 | 31.43% |
| June 30, 2016 | 20.40% |
| March 31, 2016 | 29.98% |
| December 31, 2015 | -7.68% |
| September 30, 2015 | 40.56% |
| June 30, 2015 | 41.97% |
| March 31, 2015 | 37.35% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Orexo AB | -137.1% |
| Camurus AB | 92.70% |
| Moberg Pharma AB | 65.36% |
| Infant Bacterial Therapeutics AB | -- |
| AstraZeneca PLC | 76.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.17% |
| Return on Assets | 0.83% |
| Return on Invested Capital | 0.93% |
| Profit Margin (Quarterly) | 3.54% |
| Operating Margin (Quarterly) | 7.63% |
| Return on Net Operating Assets | 0.87% |